Introduction
Increased serum concentrations of free fatty acids (FFA) derived from adipocyte lipolysis are frequently observed in overweight individuals. 1 If elevated serum FFAs were just the results of increased adipose tissue, interindividual FFA differences should disappear after adjusting for measures of adiposity. However, it is evident that fasting and daylong FFA concentrations vary dramatically among overweight individuals, and they do not solely reflect constant rates of adipocyte lipolysis. 2 Moreover, changes in circulating FFA following moderate weight loss are not always equal even in the same person. 2 These effects cannot be entirely accounted by alterations in the action of the major lipolysis-regulating hormones, insulin and catecholamines. [2] [3] [4] Lipolysis occurs at the surface of the intracellular lipid droplet, where perilipins (PLINs), a family of phosphoproteins, are located. 5, 6 Perilipins are found primarily in adipocytes and are required to activate lipolysis in stimulated states such as fasting or exercise, as well as to protect cellular triglycerides against hydrolysis in the basal state. 7 According to a functional study, PLIN isoforms (A-D) may operate with different efficiency in protecting the stored fat against the protein kinase A-mediated lipolysis. 8 Recent studies have reported significant associations between genetic variants at this PLIN locus and body-weight or obesity risk. [9] [10] [11] Based on this evidence, we hypothesize that genetic variation at the PLIN gene can modulate circulating FFA, lipolytic rate and adiposity of humans, both in the basal and the stimulated states such as weight loss. 1 In this study, we determined the associations between single-nucleotide polymorphism (SNPs) at the PLIN locus and circulating FFAs and abdominal fat distribution in response to weight loss following caloric restriction. We also examined the relationship between circulating FFA levels and oxidative stress such as oxidized low-density lipoprotein (LDL) and urinary excretion of prostaglandin F 2a (PGF 2a ). 12 
Materials and methods

Study subjects
Non-diabetic/overweight-obese Korean men and women (n ¼ 177, BMIX25 kg/m 2 ) were recruited from participants in a prospective human genetic study, supported by a Genome Research Development Project on Health and Medicine. Subjects participated in a 12-week weight-loss program conducted by the National Research Laboratory of Clinical Nutrigenetics/Nutrigenomics at Yonsei University. Patients with orthopedic limitations, weight loss/gain over the previous 6 months or any diagnosis of diabetes, cardiovascular, liver, renal, thyroid or pituitary disease were excluded. None of them were taking any medication. Written informed consent was obtained from all subjects and the protocol was approved by the Institutional Review Board of Yonsei University.
Protocol for weight loss
All subjects participated in a 12-week calorie restriction (À300 kcal/day) program. Subjects were instructed by well-trained dietitians to achieve the goal for at least 3% of weight reduction from their initial body weight; they were instructed to select low-calorie food replacing high-calorie ones, change the cooking methods and reduce the frequency of snack consumption. Usual dietary intakes were obtained using a 24-h recall method and a semiquantitative food frequency questionnaire. We used the former to carry out analyses and the latter to check if the data collected by 24-h recall methods were representative of the usual dietary pattern. Nutrient intake data at baseline and after 12 weeks were calculated as mean values from a 3-day food record (2 week days and 1 weekend) using the database of the computerized Korean food code, based on food composition tables by the National Rural Living Science Institute (7th ed., 2000) in Korea. Total energy expenditure (kcal/day) was calculated from activity patterns including basal metabolic rate calculated with the Harris-Benedict equation, physical activity for 24 h, and specific dynamic action of food. To evaluate and reinforce the subjects' compliance during the whole intervention period, dietitians interviewed them on a biweekly phone call and a monthly visit check.
Blood collection
Venous blood specimens were collected in ethylenediamine tetraacetate-treated and in plain tubes after a 12-h fast. The tubes were immediately placed on ice until their arrival to the laboratory (within 1-3 h) and stored at À701C until analysis.
Genotyping
Genomic DNA was extracted from 5 ml of whole blood using a commercially available DNA isolation kit (WIZARD R Genomic DNA purification kit, Promega Corp., Madison, WI, USA) according to the manufacturer's protocol. We genotyped seven previously reported SNPs (6209T4C, 10076C4G, 10171A4T, 11482G4A, 13042A4G, 13048C4T and 14995A4T) 8, 10, 11 ( Figure 1 ). Waist circumference was measured in the standing position after normal expiration. Blood pressure was read from the left arm with an automatic blood pressure monitor (TM-2654, Tokyo, Japan), while subjects remained seated after 20 min rest. An average of three measurements was recorded for each subject.
Abdominal fat distribution 1st and 4th lumbar levels using computerized tomography scanner Abdominal fat areas were measured by computerized tomography scanning using a General Electric High Speed Advantage 9800 scanner (Milwaukee, WI). Two crosssectional images were made for each subject: abdomen at the levels of 1st lumbar (L1) vertebra and 4th lumbar (L4) vertebra.
Serum lipid profile
Fasting serum total cholesterol and triglycerides concentrations were measured using commercially available kits on a Hitachi 7150 Autoanalyzer (Hitachi Ltd., Tokyo, Japan). After precipitation of serum chylomicron, LDL and very lowdensity lipoprotein with dextran sulfate-magnesium, high density lipoprotein (HDL) cholesterol left in the supernatant was measured by an enzymatic method. Low-density lipoprotein cholesterol was estimated indirectly using the Friedewald formula for subjects with serum triglycerides concentrations o4.52 mol/l (400 mg/ml).
Glucose, insulin and free fatty acids and homeostasis model assessment-insulin resistance Fasting glucose was measured by a glucose oxidase method using the Beckman Glucose Analyzer (Beckman Instruments, Irvine, CA, USA). Insulin was measured by radioimmunoassays with commercial kits from Immuno Nucleo Corporation (Stillwater, MN, USA). Free fatty acids were analyzed with a Hitachi 7150 autoanalyzer (Hitachi Ltd, Tokyo, Japan). Insulin resistance was calculated with the homeostasis model assessment (HOMA) using the following equation: IR ¼ {fasting insulin (mIU/ml) Â fasting glucose (mmol/l)}/22.5.
Plasma oxidized low-density lipoprotein
Plasma oxidized LDL (ox-LDL) was measured using an enzyme immunoassay (Mercodia, Uppsala, Sweden). The resultant color reaction was read using a Victor 2 (PerkinElmer Life Sciences, Turku, Finland) at 450 nm. It was indicated as U/l.
Urinary excretion of prostaglandin F 2a
Urine was collected after a 12-h fast in polyethylene bottles containing 1% butylated hydroxytoluene before blood collection. 8-epi-Prostaglandin F 2a was measured using an enzyme immunoassay (BIOXYTECH urinary 8-epi-PGF 2a t Assay kit, OXIS International Inc., OR, USA). Urinary creatinine was determined by the alkaline picrated (Jeffe) reaction and urinary PGF 2a concentrations were expressed as picogram per milligram (pg/mg) of creatinine.
Statistical analysis and power calculation
Statistical analysis was carried out using SPSS version 12.0 for Windows (Statistical Package for the Social Science, SPSS Ins., Chicago, IL, USA). Linkage disequilibrium (LD) was examined using Executive SNP Analyzer1.0 (http://www. istech21.com/index.html) and haplotypes were constructed using the available LD among SNPs. Associations between haplotypes and continuous variables before and after weight loss were examined using paired t-test. Comparison of net differences among haplotype groups was tested with oneway analysis of variance followed by Tukey's test and a general linear model followed by Bonferroni method with adjustment for covariate if differences were shown in baseline clinical characteristics. Each variable was examined for normal distribution and significantly skewed variables were log-transformed. For descriptive purposes, mean values are presented on untransformed and unadjusted variables.
Results are expressed as mean7s.e. A two-tailed value of Po0.05 was considered statistically significant. We calculated statistical power using the PS program (power and sample size calculation program ver2.1.31) for the main outcomes. Assuming net differences of body weight (1.0000), abdominal fat areas at L4 vertebrae (total fat: 0.9897 and visceral fat: 1.0000), FFAs (0.7916), ox-LDL (0.9098) and urinary 8-epi-PGF 2a (0.8910), the power of the study was B0.8 for each of these variables.
Results
Allele frequencies and linkage disequilibrium of the polymorphic genetic variants in the perilipin locus We genotyped seven PLIN SNPs (6209T4C, 10076C4G, 10171A4T, 11482G4A, 13042A4G, 13048C4T and 14995A4T) in 177 non-diabetic/overweight-obese subjects (40 men/137 women). Perilipin genotypes, allele frequencies, LD coefficients and correlation coefficients for the seven SNPs are shown in Table 1 . Alleles were called as 1 or 2 (1 for major allele and 2 for minor allele): 1 for T at SNP 6209T4C, C at 10076C4G, A at 10171A4T, G at 11482G4A, A at 13042A4G, C at 13048C4T, A at 14995A4T and 2 for C at SNP 6209T4C, G at 10076C4G, T at 10171A4T, A at 11482G4A, G at 13042A4G, T at 13048C4T, T at 14995A4T. Genotype distributions did not deviate from Hardy-Weinberg equilibrium. Allele 2 at PLIN 14995A4T General characteristics of the study subjects before and after a 12-week low-caloric diet Table 2 shows anthropometric and clinical parameters before and after a 12-week low-calorie diet. The low-calorie diet induced a mild weight loss of about 4.6% and significant reductions in abdominal fat areas and blood pressure. This dietary intervention induced a beneficial effect on a number of cardiovascular risk factors, including serum lipids, glucose, insulin and FFA concentrations, as well as HOMA-IR.
Associations between perilipin single nucleotide polymorphisms and change in free fatty acid levels At baseline, we did not find any significant allele related association among any of the seven SNPs examined and plasma FFA concentrations (Table 3) . Subjects after the 12-week trial had a mean FFA reduction of 64.1719.9 mEq/l (10.7%). GG subjects at SNP10076C4G experienced significantly higher reduction of FFA compared with CC carriers before (P3 ¼ 0.010) and after adjustment for age, gender and BMI (P4 ¼ 0.009). G carriers at SNP11482G4A or A carriers at SNP14995A4T also had reductions in FFA concentrations. On the other hand, carriers of homozygous rare alleles at either SNP11482 (P3 ¼ 0.045, P4 ¼ 0.020) or SNP14995 (P3 ¼ 0.029, P4 ¼ 0.048) had increased FFAs (Table 3) . We also found haplotype-related differences for 10076C4 G/10171A4T (P1 ¼ 0.044, P2 ¼ 0.034) or 11482G4A/ 14995A4T (P1 ¼ 0.018, P2 ¼ 0.032) regarding changes on circulating FFA levels before and after adjustment for age, gender and BMI (Figure 2 ). However, we did not find significant allele-related differences for 6209T4C, 10171A4T, 13042A4G and 13048C4T on changes in FFA levels. 
Genetic variants PLIN gene differently respond to the weight loss Y Jang et al
Effects of 12-week low-calorie diet on abdominal fat distribution and lipid peroxides according to perilipin 11482G4A/ 14995A4T or 10076C4G/10171A4T haplotypes There were no significant haplotype-related differences in age, gender distribution, baseline values of waist circumference, abdominal fat areas and weight reduction according to 11482G4A/14995A4T or 10076C4G/10171A4T haplotypes (Table 4) . For 11482G4A/14995A4T haplotypes, subjects with nGA/nGA showed greater reduction in waist circumference and total fat area at the L4 level than those with the GA/GA haplotype which still remained after adjusting for age and gender (Table 4, Figure 3 ). Reduction in visceral fat area at L4 was greater in nGA carriers than GA/GA subjects both before and after adjustment for covariates (Figure 3) .
Baseline levels of urinary PGF 2a (GA/GA:1340.17197.0, GA/nGA:862.5787.4, nGA/nGA:815.97199.0, Po0.05) and ox-LDL (GA/GA:44.072.74, GA/nGA:38.572.00, nGA/ nGA:34.972.84, Po0.05) were higher in GA/GA subjects as compared with nGA haplotype carriers. After the dietary intervention, these two variables were greatly reduced in GA/GA haplotype carriers than in nGA haplotype carriers. This effect remained significant after adjusting for baseline levels, age, gender and BMI (Figure 3) . On the other hand, concentrations of urinary PGF 2a were paradoxically increased in nGA haplotype carriers. Insulin resistance ¼ {fasting insulin (mIU/ml) Â fasting glucose (mmol/l)}/22.5. PLIN SNP, perilipin single-nucleotide polymorphism. Data are given as mean7s.e. Tested by one-way ANOVA with Tukey's test or general linear model followed by Bonferroni methods at baseline and change, respectively. There were no significant differences in baseline FFAs. Significant differences (Po0.05) were indicated by the alphabets. Sharing the same alphabet indicates no significant differences among changes of FFA levels in the same row. 1 for major allele, 2 for minor allele, P1 and P3: unadjusted P-value, P2 and P4: adjusted for age, gender and BMI. Tested by one-way analysis of variance (ANOVA) with Tukey's test or general linear model followed by Bonferroni methods on FFA change, Significant differences (Po0.05) was indicated by the alphabet. Sharing the same alphabet indicates no significant differences among changes in FFA levels. P1: unadjusted P-value, P2: adjusted for age, gender and BMI.
Genetic variants PLIN gene differently respond to the weight loss Y Jang et al For 10076C4G/10171A4T haplotypes, there were no significant haplotype-related differences for changes in abdominal fat distribution and lipid peroxides (Table 4) .
Discussion
The most relevant and novel finding from this study was that fasting plasma FFA changes following a modest weight loss (4.6% of initial body weight) in overweight-obese subjects are influenced by the genetic variability at the PLIN locus. Furthermore, circulating FFA changes rather than body fat itself may be responsible for the changes in lipid peroxides such as urinary PGF 2a and ox-LDL.
Following the weight reduction dietary intervention, subjects carrying the rare allele homozygous rare alleles at PLIN 10076C4G had greater reduction in FFA levels than those with C/C genotype. On the other hand, subjects homozygous for the rare alleles at either 11482G4A or 14995A4T SNPs showed increases of FFA levels, whereas carriers of the major alleles had the reductions in FFA concentrations. These patterns were also similarly shown in haplotype analysis (PLIN 10076C4G/10171A4T, PLIN 11482G4A/14995A4T). It has been reported that A allele at PLIN 11482G4A polymorphism was associated with decreased PLIN content and increased basal and noradrenaline induced lipolytic activity in Swedish obese women (BMIX30 kg/m 2 ).
1 However, such effects have not been reported for PLIN 14995A4T. This discrepant association between variants PLIN and changes in FFA levels could relate to the expression of different PLIN isoforms, which may have PLINs are also required to facilitate HSL translocation to the lipid droplet and hydrolysis of triglycerides in stimulated states, such as fasting. 7 Thus, the greater reduction of FFA levels in nCA/nCA subjects at 10076C4G/10171A4T haplotype may partially result from an associated impairment of the perilipin inhibitory actions in PKA-mediated lipolysis in response to calorie restriction. In this regard, Souza et al.
17
found that mutant perilipin blocked PKA-stimulated lipolysis. In addition, perilipin was found to be necessary to elicit an effect of PKA on lipolysis in both cell models and adipocytes from perilipin-null mice. 8, 16 Conversely, nGA/nGA carriers at 11482G4A/14995A4T had increased FFA concentrations after weight loss, which may be explained as a consequence of accelerated lipolysis resulting in rapid fat loss, secondary to reduced perilipin expression in adipose tissue. In fact, in the study subjects with the nGA/nGA haplotype showed a greater reduction in visceral and total fat areas at L4 than those with the GA/GA haplotype. MottaguiTabar et al. 1 have also suggested a negative association between PLIN 11482G4A SNP and body fat. Based on these results, it could be hypothesized that PLIN 11482G4A/14995A4T or PLIN 10076C4G/10171A4T haplotypes may be associated with the process of splicing. 18 Differently spliced mRNAs are translated to yield different protein isoforms 19, 20 with different lipolytic efficiency.
Elevated circulating FFA levels are known to increase the oxidative stress levels and be associated with increased lipid peroxidation as determined by urinary 8-epi-PGF 2a and circulating ox-LDL in healthy subjects. 12, 21 In vitro evidence also indicates that elevated FFAs have adverse effects on oxidative status, including the generation of reactive oxygen species. 22 In our study, subjects with GA/GA haplotype at PLIN 11482G4A/14995A4T showed greater reduction in PGF 2a and ox-LDL than those with the nGA/nGA haplotypes, even though they had lower reduction in total and visceral fat at L4. On the other hand, nGA haplotype carriers had an increase of 8-epi-PGF 2a after weight reduction. These patterns still remained after adjusting for age, gender, BMI and the initial value of each 8-epi-PGF 2a or ox-LDL. Thus, this haplotype effect on lipid peroxides might be related to the change in FFA levels after weight loss rather than change in visceral fat areas.
